Inhibiting p38 mitogen-activated protein kinase attenuates cerebral ischemic injury in Swedish mutan

• 作 者: Liangyu Zou Haiyan Qin Yitao H
• 机 构: Department of Neurology
• 出 处: 中国神经再生研究（英文版）
• 发表日期: 2004年期
• 关键词: cerebral ischemia amyloid precursor protein transgenic Alzheimer's disease

Cerebral ischemia was induced using photothrombosis 1 hour after intraperitoneal injection of the p38 mitogen-activated protein kinase (MAPK) inhibitor SB239063 into Swedish mutant amyloid precursor protein (APP/SWE) transgenic and non-transgenic mice. The number of surviving neurons in the penumbra was quantified using Nissl staining, and the activity of p38 MAPKs was measured by western blotting. The number of surviving neurons in the penumbra was significantly reduced in APP/SWE transgenic mice compared with non-transgenic controls 7 days after cerebral ischemia, but the activity of p38 MAPKs was significantly elevated compared with the non-ischemic hemisphere in the APP/SWE transgenic mice. SB239063 prevented these changes. The APP/SWE mutation exacerbated ischemic brain injury, and this could be alleviated by inhibiting p38 MAPK activity.